Education
About Us
Working with TipRanks
Follow Us
LifeMD (LFMD)
NASDAQ:LFMD
Total Valuation
LifeMD has a market cap or net worth of $434.48M. The enterprise value is $365.50M.
Market Cap$434.48M
Enterprise Value$365.50M
Share Statistics
LifeMD has 45,447,605 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45,447,605
Owned by Insiders17.79%
Owned by Institutions0.75%
Financial Efficiency
LifeMD’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is >-0.01%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)-0.26
Return on Invested Capital (ROIC)>-0.01%
Return on Capital Employed (ROCE)-1.32
Revenue Per Employee698.86K
Profits Per Employee-62.11K
Employee Count304
Asset Turnover2.93
Inventory Turnover-10.71
Valuation Ratios
The current PE Ratio of LifeMD is -10.80. LifeMD’s PEG ratio is -1.03.
PE Ratio-10.80
PS Ratio0.00
PB Ratio-63.55
Price to Fair Value>-0.01
Price to FCF62.81
Price to Operating Cash Flow19.91
PEG Ratio-1.03
Income Statement
In the last 12 months, LifeMD had revenue of 212.45M and earned -18.88M in profits. Earnings per share was -0.53.
Revenue212.45M
Gross Profit242.40M
Operating Income-16.14M
Pretax Income-18.33M
Net Income-18.88M
EBITDA-6.65M
Earnings Per Share (EPS)-0.53
Cash Flow
In the last 12 months, operating cash flow was 17.51M and capital expenditures -11.54M, giving a free cash flow of 5.98M billion.
Operating Cash Flow17.51M
Free Cash Flow5.98M
Free Cash Flow per Share0.13
Dividends & Yields
LifeMD pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.62
52-Week Price Change37.97%
50-Day Moving Average6.29
200-Day Moving Average5.63
Relative Strength Index (RSI)82.09
Average Volume (3m)1.96M
Important Dates
LifeMD upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 6, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date―
Financial Position
LifeMD as a current ratio of 0.81, with Debt / Equity ratio of -457.63%
Current Ratio0.81
Quick Ratio0.76
Debt to Market Cap0.09
Net Debt to EBITDA1.49
Interest Coverage Ratio0.00
Taxes
In the past 12 months, LifeMD has paid 402.00K in taxes.
Income Tax402.00K
Effective Tax Rate-0.02
Enterprise Valuation
LifeMD EV to EBITDA ratio is -29.16, with an EV/FCF ratio of 32.46.
EV to Sales0.91
EV to EBITDA-29.16
EV to Free Cash Flow32.46
EV to Operating Cash Flow11.08
Balance Sheet
LifeMD has $35.00M in cash and marketable securities with $25.10M in debt, giving a net cash position of -$9.90M billion.
Cash & Marketable Securities$35.00M
Total Debt$25.10M
Net Cash-$9.90M
Net Cash Per Share-$0.22
Tangible Book Value Per Share-$49.29K
Margins
Gross margin is 92.21%, with operating margin of -7.60%, and net profit margin of -8.89%.
Gross Margin92.21%
Operating Margin-7.60%
Pretax Margin-8.63%
Net Profit Margin-8.89%
EBITDA Margin-3.13%
EBIT Margin-7.60%
Analyst Forecast
The average price target for LifeMD is $11.57, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$11.57
Price Target Upside19.65% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast43.07%
EPS Growth Forecast55.40%